UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000061387
Receipt number R000070237
Scientific Title A Prospective Interventional Study to Evaluate Changes in Pulmonary Function Following Carbon-Ion Radiotherapy for Lung Tumors
Date of disclosure of the study information 2026/04/27
Last modified on 2026/04/27 14:04:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A prospective interventional study evaluating changes in pulmonary function following carbon-ion radiotherapy for lung tumors

Acronym

Pulmonary function after carbon-ion radiotherapy for lung tumors

Scientific Title

A Prospective Interventional Study to Evaluate Changes in Pulmonary Function Following Carbon-Ion Radiotherapy for Lung Tumors

Scientific Title:Acronym

Prospective study of pulmonary function afafte carbon-ion radiotherapy for lung tumors

Region

Japan


Condition

Condition

Patients receiving carbon-ion radiotherapy for primary lung cancer or metastatic lung tumors

Classification by specialty

Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To prospectively evaluate pulmonary function in patients with primary lung cancer or metastatic lung tumors treated with carbon-ion radiotherapy, and to analyze the impact of the treatment on respiratory function and its association with follow-up data, including post-treatment adverse events.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Absolute and percentage changes in pulmonary function before and after carbon-ion radiotherapy

Key secondary outcomes

Association between changes in pulmonary function and factors including the occurrence of adverse events and dosimetric parameters


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Maneuver

Interventions/Control_1

Pulmonary function tests at approximately 3, 6, and 12 months after carbon-ion radiotherapy

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Patients scheduled to undergo carbon-ion radiotherapy for primary lung cancer or metastatic lung tumors between the date of institutional approval and December 31, 2029, OR patients who have provided consent for the existing study at our institution (N25-013: A prospective observational study evaluating changes in pulmonary function following carbon-ion radiotherapy for lung tumors), provided they are capable of giving written informed consent for this study.

2. Patients aged 18 years or older at the time of informed consent (regardless of gender).

3. Patients who are scheduled to visit our institution for follow-up for at least 1 year after the completion of treatment.

4. Patients judged by an investigator or attending physician to be capable of understanding the informed consent document.

Key exclusion criteria

Patients judged by an investigator or attending physician to be ineligible for this study

Target sample size

250


Research contact person

Name of lead principal investigator

1st name Ryo
Middle name
Last name Karita

Organization

National Institutes for Quantum Science and Technology QST hospital

Division name

Section of Head, Neck and Thoracic Tumors, Department of Treatment and Diagnosis

Zip code

263-8555

Address

4-9-1 Anagawa, Inage-ku, Chiba-shi, Chiba

TEL

043-206-3306

Email

karita.ryo@qst.go.jp


Public contact

Name of contact person

1st name Ryo
Middle name
Last name Karita

Organization

National Institutes for Quantum Science and Technology QST hospital

Division name

Section of Head, Neck and Thoracic Tumors, Department of Treatment and Diagnosis

Zip code

263-8555

Address

4-9-1 Anagawa, Inage-ku, Chiba-shi, Chiba

TEL

043-206-3306

Homepage URL


Email

karita.ryo@qst.go.jp


Sponsor or person

Institute

National Institutes for Quantum Science and Technology QST hospital

Institute

Department

Personal name



Funding Source

Organization

National Institutes for Quantum Science and Technology QST hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Institutes for Quantum Science and Technology Institutional Review Board

Address

4-9-1 Anagawa, Inage-ku, Chiba-shi, Chiba

Tel

043-382-3703

Email

helsinki@qst.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立研究開発法人量子科学技術研究開発機構QST病院


Other administrative information

Date of disclosure of the study information

2026 Year 04 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 03 Month 18 Day

Date of IRB

2026 Year 04 Month 27 Day

Anticipated trial start date

2026 Year 05 Month 04 Day

Last follow-up date

2030 Year 12 Month 31 Day

Date of closure to data entry

2030 Year 12 Month 31 Day

Date trial data considered complete


Date analysis concluded

2031 Year 06 Month 30 Day


Other

Other related information



Management information

Registered date

2026 Year 04 Month 27 Day

Last modified on

2026 Year 04 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000070237